• Igor

    June 23, 2020 at 2:52 pm

    I saw a video where patients from phase 2 trial shown a good recovery progression.

    A speaker told that this therapy slow down regression up to 80% as I remember.

    I don’t like this collaboration because it is for process not for result.


    I prefer this associations to reduce placebo patients and find the lobby to make FDA gives improvement for this therapy



Log in to reply.